U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Public Meeting on Patient-Focused Drug Development for Vitiligo - 03/08/2021 - 03/08/2021
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
Public Meeting on Patient-Focused Drug Development for Vitiligo
March 8, 2021

Date:
March 8, 2021

On March 8, 2021, FDA hosted a virtual public meeting on Patient-Focused Drug Development for Vitiligo. FDA was interested in hearing patients’ perspectives on the impact of vitiligo on daily life and patient views on treatment approaches.

Date:

March 8, 2021

Time:

10:00 a.m. - 2:30 p.m. EST

Location:

VIRTUAL EVENT

Meeting Materials

Public Docket:

In addition to providing input at the public meeting, stakeholders are invited to provide their perspectives on the discussion questions through the public docket.

  • The docket closes on May 10, 2021. FDA is interested in responses to the questions listed in the public docket.

Related Information:

Back to Top